Back
NovaBay Pharmaceuticals, Inc. 10K Form
Sell
37
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$1.08
Seasonality Move:
-8.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NBY News And Ratings
See the #1 stock for the next 7 days that we like better than NBY
NBY Financial Statistics
Sales & Book Value
| Annual Sales: | $9.8M |
|---|---|
| Cash Flow: | $-1.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.45 |
| Price / Book: | 1.5 |
Profitability
| EPS (TTM): | 0.59530 |
|---|---|
| Net Income (TTM): | $-8M |
| Gross Margin: | $6.5M |
| Return on Equity: | -306.03% |
| Return on Assets: | -56.74% |
NovaBay Pharmaceuticals, Inc. Earnings Forecast
Key NovaBay Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 22 years for NBY is 66.26%.
-
The Selling, General & Administrative Expenses for NBY have been equal to 116.69% of Gross Profit Margin.
-
The Research & Development expenses have been 0.43% of Revenue.
-
The Net Earning history of NBY is -73.71% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 12 years.
NovaBay Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NBY |
| CUSIP: | 66987P |
| Website: | novabay.com |
Debt
| Debt-to-Equity Ratio: | 0.59 |
|---|---|
| Current Ratio: | 1.98 |
| Quick Ratio: | 1.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NBY Technical Analysis vs Fundamental Analysis
Sell
37
NovaBay Pharmaceuticals, Inc. (NBY)
is a Sell
Is NovaBay Pharmaceuticals, Inc. a Buy or a Sell?
-
NovaBay Pharmaceuticals, Inc. stock is rated a SellThe current NovaBay Pharmaceuticals, Inc. [NBY] share price is $1.06. The Score for NBY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.